{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:12:19Z","timestamp":1769501539267,"version":"3.49.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Physiology & Behavior"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.physbeh.2008.06.012","type":"journal-article","created":{"date-parts":[[2008,7,1]],"date-time":"2008-07-01T09:13:13Z","timestamp":1214903593000},"page":"341-347","source":"Crossref","is-referenced-by-count":23,"title":["Effect of inhibiting carnitine biosynthesis on male rat sexual performance"],"prefix":"10.1016","volume":"95","author":[{"given":"Maija","family":"Dambrova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Cirule","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baiba","family":"Svalbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liga","family":"Zvejniece","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Osvalds","family":"Pugovichs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatjana","family":"Zorenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivars","family":"Kalvinsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edgars","family":"Liepinsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irina","family":"Belozertseva","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.physbeh.2008.06.012_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1320.001","article-title":"The role of the carnitine system in human metabolism","volume":"1033","author":"Foster","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.physbeh.2008.06.012_bib2","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1096\/fasebj.6.15.1464372","article-title":"Carnitine function and requirements during the life cycle","volume":"6","author":"Rebouche","year":"1992","journal-title":"FASEB J"},{"key":"10.1016\/j.physbeh.2008.06.012_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1095\/biolreprod44.3.448","article-title":"Puberty in the male chimpanzee: progressive maturation of semen characteristics","volume":"44","author":"Marson","year":"1991","journal-title":"Biol Reprod"},{"key":"10.1016\/j.physbeh.2008.06.012_bib4","doi-asserted-by":"crossref","first-page":"6422","DOI":"10.1021\/bi00321a022","article-title":"l-carnitine dissimilation in the gastrointestinal tract of the rat","volume":"23","author":"Rebouche","year":"1984","journal-title":"Biochemistry"},{"key":"10.1016\/j.physbeh.2008.06.012_bib5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1146\/annurev.bi.57.070188.001401","article-title":"Carnitine","volume":"57","author":"Bieber","year":"1988","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.physbeh.2008.06.012_bib6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1095\/biolreprod37.1.68","article-title":"Localization of gamma-butyrobetaine hydroxylase in the rat testis","volume":"37","author":"Carter","year":"1987","journal-title":"Biol Reprod"},{"key":"10.1016\/j.physbeh.2008.06.012_bib7","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/humupd\/2.2.87","article-title":"Role of free l-carnitine and acetyl-l-carnitine in post-gonadal maturation of mammalian spermatozoa","volume":"2","author":"Jeulin","year":"1996","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.physbeh.2008.06.012_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1196\/annals.1320.017","article-title":"The role of carnitine in the male reproductive system","volume":"1033","author":"Ng","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.physbeh.2008.06.012_bib9","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S1472-6483(10)60920-0","article-title":"Carnitines and male infertility","volume":"8","author":"Agarwal","year":"2004","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.physbeh.2008.06.012_bib10","first-page":"28","article-title":"Male infertility: nutritional and environmental considerations","volume":"5","author":"Sinclair","year":"2000","journal-title":"Altern Med Rev"},{"key":"10.1016\/j.physbeh.2008.06.012_bib11","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1016\/j.eururo.2007.04.042","article-title":"Antioxidant treatment associated with sildenafil reduces monocyte activation and markers of endothelial damage in patients with diabetic erectile dysfunction: a double-blind, placebo-controlled study","volume":"52","author":"Morano","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib12","first-page":"143","article-title":"Level of free l-carnitine in human seminal plasma and its correlation with semen quality","volume":"13","author":"Li","year":"2007","journal-title":"Zhonghua Nan Ke Xue"},{"key":"10.1016\/j.physbeh.2008.06.012_bib13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.urology.2003.11.009","article-title":"Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging","volume":"63","author":"Cavallini","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.physbeh.2008.06.012_bib14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/j.1439-0272.1994.tb00780.x","article-title":"l-carnitine in idiopathic asthenozoospermia: a multicenter study. Italian Study Group on Carnitine and Male Infertility","volume":"26","author":"Costa","year":"1994","journal-title":"Andrologia"},{"key":"10.1016\/j.physbeh.2008.06.012_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.juro.2006.06.006","article-title":"Drug therapy for idiopathic male infertility: rationale versus evidence","volume":"176","author":"Kumar","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib16","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.fertnstert.2003.10.034","article-title":"A placebo-controlled double-blind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia","volume":"81","author":"Lenzi","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.physbeh.2008.06.012_bib17","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0015-0282(02)04679-4","article-title":"Use of carnitine therapy in selected cases of male factor infertility: a double-blind crossover trial","volume":"79","author":"Lenzi","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/j.physbeh.2008.06.012_bib18","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1097\/01.fjc.0000250077.07702.23","article-title":"Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction","volume":"48","author":"Liepinsh","year":"2006","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib19","series-title":"Pharmaceutial composition comprising gamma-butyrobetaine for stimulating the sexual activity and potency","author":"Kalvinsh","year":"2003"},{"key":"10.1016\/j.physbeh.2008.06.012_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0303-7207(78)90009-6","article-title":"Accumulation of carnitine in rat epididymis after injection of [3H]butyrobetaine in vivo: quantitative aspects, and the effects of androgens and antiandrogens","volume":"11","author":"Bohmer","year":"1978","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib21","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1046\/j.1365-2605.2002.00335.x","article-title":"Androgen administration in middle-aged and ageing men: effects of oral testosterone undecanoate on dihydrotestosterone, oestradiol and prostate volume","volume":"25","author":"Pechersky","year":"2002","journal-title":"Int J Androl"},{"key":"10.1016\/j.physbeh.2008.06.012_bib22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0006-2952(88)90717-4","article-title":"3-(2,2,2-Trimethylhydrazinium)propionate (THP)\u2014a novel gamma-butyrobetaine hydroxylase inhibitor with cardioprotective properties","volume":"37","author":"Simkhovich","year":"1988","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib23","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0022-3565(24)38111-X","article-title":"Pharmacokinetic analysis of the cardioprotective effect of 3-(2,2, 2-trimethylhydrazinium) propionate in mice: inhibition of carnitine transport in kidney","volume":"289","author":"Kuwajima","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.physbeh.2008.06.012_bib24","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1046\/j.1432-1327.2001.02065.x","article-title":"Development and characterization of an animal model of carnitine deficiency","volume":"268","author":"Spaniol","year":"2001","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.physbeh.2008.06.012_bib25","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1021\/mp070023l","article-title":"Transport of organic cations across the blood\u2013testis barrier","volume":"4","author":"Maeda","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib26","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.105.586107","article-title":"Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5)","volume":"113","author":"Grube","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.physbeh.2008.06.012_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1385-299X(96)00036-0","article-title":"Male rat sexual behavior","volume":"1","author":"Agmo","year":"1997","journal-title":"Brain Res Brain Res Protoc"},{"key":"10.1016\/j.physbeh.2008.06.012_bib28","series-title":"WHO laboratory manual for the examination of human semen and sperm\u2013cervical mucus interaction","first-page":"1","author":"World Health Organization","year":"1999"},{"key":"10.1016\/j.physbeh.2008.06.012_bib29","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1248\/bpb.23.770","article-title":"Effects of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on tissue carnitine and lipid levels in rats","volume":"23","author":"Hayashi","year":"2000","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.physbeh.2008.06.012_bib30","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1023\/B:MCBI.0000012853.20116.06","article-title":"Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat","volume":"258","author":"Degrace","year":"2004","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.physbeh.2008.06.012_bib31","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1472-8206.1997.tb00849.x","article-title":"Effect of MET-88, a gamma-butyrobetaine hydroxylase inhibitor, on myocardial derangements induced by hydrogen peroxide in the isolated perfused rat heart","volume":"11","author":"Akahira","year":"1997","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.physbeh.2008.06.012_bib32","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.biochi.2007.10.002","article-title":"Characteristics of l-carnitine import into heart cells","volume":"90","author":"Rigault","year":"2008","journal-title":"Biochimie"},{"key":"10.1016\/j.physbeh.2008.06.012_bib33","doi-asserted-by":"crossref","first-page":"20816","DOI":"10.1074\/jbc.M611391200","article-title":"Regulation of lipid flux between liver and adipose tissue during transient hepatic steatosis in carnitine-depleted rats","volume":"282","author":"Degrace","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.physbeh.2008.06.012_bib34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/0009-8981(76)90261-8","article-title":"Plasma carnitine and body composition","volume":"67","author":"Cederblad","year":"1976","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.physbeh.2008.06.012_bib35","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1050-1738(02)00175-5","article-title":"Mildronate: cardioprotective action through carnitine-lowering effect","volume":"12","author":"Dambrova","year":"2002","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.physbeh.2008.06.012_bib36","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1527-3458.2005.tb00267.x","article-title":"Mildronate: an antiischemic drug for neurological indications","volume":"11","author":"Sjakste","year":"2005","journal-title":"CNS Drug Rev"},{"key":"10.1016\/j.physbeh.2008.06.012_bib37","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1080\/10604450213832","article-title":"Involvement of nitric oxide production in the mildronate mechanism of action","volume":"12","author":"Dzintare","year":"2002","journal-title":"Pharmacol Rev Commun"},{"key":"10.1016\/j.physbeh.2008.06.012_bib38","series-title":"Changes of concentration of nitric oxide in tissues under action of different pharmacological agents","first-page":"1","author":"Dzintare","year":"2004"},{"key":"10.1016\/j.physbeh.2008.06.012_bib39","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0014-2999(95)00578-1","article-title":"Nitric oxide is involved in male sexual behavior of rats","volume":"294","author":"Benelli","year":"1995","journal-title":"Eur J Pharmacol"}],"container-title":["Physiology & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938408002059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031938408002059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T22:20:21Z","timestamp":1738275621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031938408002059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0031938408002059"],"URL":"https:\/\/doi.org\/10.1016\/j.physbeh.2008.06.012","relation":{},"ISSN":["0031-9384"],"issn-type":[{"value":"0031-9384","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}